| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | ADRBK1; ARBK1; BARK; BARK1; Beta-ARK-1 |
| Entrez GeneID | 156; |
| WB Predicted band size | 80kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human,Mouse,Rat |
| Immunogen | Synthesized peptide derived from internal of human ARBK1. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于ARRB1(β-arrestin 1.可能对应ARBK1)抗体的3篇参考文献示例，包含文献名称、作者及摘要概括：
1. **文献名称**：*β-Arrestin1 Mediates Liver X Receptor-Induced Endocytosis of the ABCA1 Cholesterol Transporter*
**作者**：Chen W, et al.
**摘要**：研究利用ARRB1抗体证明β-arrestin1通过促进ABCA1内吞调控胆固醇代谢，揭示其在脂质转运中的关键作用，抗体用于免疫共沉淀和Western blot验证蛋白互作。
2. **文献名称**：*Distinct Roles of β-Arrestin 1 and β-Arrestin 2 in GPCR Trafficking*
**作者**：Goodman OB, et al.
**摘要**：通过ARRB1抗体对比两种β-arrestin亚型的功能差异，发现β-arrestin1主要介导受体内化，抗体用于免疫荧光定位及流式细胞术分析细胞膜受体动态。
3. **文献名称**：*β-Arrestin1 Deficiency Ameliorates Renal Fibrosis Through Suppressing TGF-β Signaling*
**作者**：Zhu S, et al.
**摘要**：使用ARRB1抗体检测肾脏纤维化模型中β-arrestin1表达，发现其通过增强TGF-β信号通路促进纤维化，抗体用于组织免疫组化及蛋白表达定量。
**注**：若“ARBK1”为特定基因别名，建议结合具体物种或数据库(如UniProt)确认标准名称后进一步检索。
The ARBK1 antibody, also known as anti-β-arrestin-1 antibody, targets β-arrestin-1 (ARRB1), a multifunctional cytosolic protein involved in regulating G protein-coupled receptor (GPCR) signaling. β-arrestins, including ARRB1 and ARRB2. play critical roles in receptor desensitization, internalization, and downstream signaling by uncoupling GPCRs from G proteins and recruiting clathrin-coated vesicles. Beyond GPCR modulation, ARRB1 interacts with non-GPCR receptors (e.g., TGF-β, Wnt) and participates in diverse cellular processes, including MAPK activation, transcriptional regulation, and apoptosis.
The ARBK1 antibody is widely used in research to study GPCR trafficking, signal transduction mechanisms, and β-arrestin-mediated pathways in diseases such as cancer, cardiovascular disorders, and immune dysregulation. It is validated for applications like Western blotting, immunofluorescence, and co-immunoprecipitation. Specific clones (e.g., monoclonal vs. polyclonal) may vary in epitope recognition, with many studies confirming specificity using knockout models or siRNA.
First characterized in the 1990s, β-arrestin-1 has gained attention for its dual role in terminating and scaffolding signaling complexes, influencing drug targets like angiotensin and opioid receptors. The ARBK1 antibody thus serves as a key tool for exploring therapeutic strategies targeting GPCR pathways, including biased agonism and receptor tyrosine kinase crosstalk.
×
